Coronary disease receiving coronary artery stents Circulatory System
Conditions
Interventions
The coronary intervention results and prognosis of 5000 people before June 2011 were traced via medical record review and telephone follow-up. These data were all digitized. All clinical data were col
Sponsors
Chang Gung Medical Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Evidence of myocardial ischemia 2. >50% stenosis in a native coronary artery or in a bypass vein graft that was suitable for stenting 3. Over 20 years old 4. Had received coronary intervention 5. Patient and family members agreed to further follow-up
Exclusion criteria
Exclusion criteria: 1. Severe multivessel disease requiring bypass surgery 2. Contraindication for aspirin, ticlopidine, clopidogrel or ticagrelor use 3. Patients who refused to undergo the procedure 4. Patients who refused further follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major adverse cardiac event (MACE) such as cardiac death, myocardial infarction (STEMI or NSTEMI), target lesion revascularization (TLR), stenting in a new lesion, and the need for emergency bypass surgery during long-term follow-up after coronary stentings | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular events during the follow-up period including total death (cardiac and non-cardiac), reinfarction (STEMI or NSTEMI), or a cerebrovascular accident (CVA) after coronary stentings | — |
Countries
Taiwan
Outcome results
None listed